Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Nature|February 28, 2014
Mouse liver repopulation with hepatocytes generated from human fibroblastsSaiyong Zhu, Milad Rezvani, Jack Harbell, et al.Environmental Health : a Global Access Science Source|July 23, 2024
Fluoride-related changes in the fetal cord blood proteome; a pilot studySami T Tuomivaara, Susan J Fisher, Steven C Hall, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Heightened Immune Activation in Fetuses with Gastroschisis May Be Blocked by Targeting IL-5Michela Frascoli, Cerine Jeanty, Shannon Fleck, et al.Research Square|March 11, 2024
Fluoride-related changes in the fetal cord blood proteome; a pilot studySami T Tuomivaara, Dana E Goin, Susan J Fisher, et al.Plos One|September 6, 2017
CD18 deficiency improves liver injury in the MCD model of steatohepatitisAndrew A Pierce, Caroline C Duwaerts, Kevin Siao, et al.Cells|July 9, 2022
Clinical Application of Induced Hepatocyte-like Cells Produced from Mesenchymal Stromal Cells: A Literature ReviewYanina Bogliotti, Mark Vander Roest, Aras N Mattis, et al.Journal of Medicinal Chemistry|December 13, 2016
A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer ModelsBenjamin Spangler, Shaun D Fontaine, Yihui Shi, et al.Cell Death and Differentiation|November 21, 2020
Hepatocyte-specific deletion of XBP1 sensitizes mice to liver injury through hyperactivation of IRE1αCaroline C Duwaerts, Kevin Siao, Russell K Soon, et al.JCI Insight|August 9, 2019
Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinomaKevin C Corbit, Camella G Wilson, Dylan Lowe, et al.Frontiers in Medicine|October 24, 2022
Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitisAmy Yu, Carson Cable, Sachin Sharma, et al.Pageof 5